About Pharmia
Pharmia is a Healthcare company based in Tuusula (Finland) founded in 1994, and was acquired by Labomar in October 2025. Contract manufacturing of food supplements and medical devices is conducted. It operates on a Professional Services and B2B2C model. Pharmia offers products and services including Dietary Supplements, Medical Devices, Product Development, Raw Materials Sourcing, and Packaging Solutions. Its focus areas include Medical Devices and Dietary Supplements. Its legal entity is Pharmia Oy.
Company details
Pharmia is recognized as a leading Finnish contract manufacturer specializing in the development and production of dietary supplements and CE-marked medical devices across Europe. Services provided include comprehensive product development from ideation to market, raw material sourcing, and innovative packaging solutions. The company operates within the healthcare sector, ensuring high-quality standards with ISO 13485 and FSSC 22000 certifications. Production processes are managed meticulously, covering everything from material procurement to final product delivery. Clients are supported with tailored formulations and competitive offers during the development phase. Emphasis is placed on quality assurance through external laboratory analyses and consistent product standards.
- Headquarters Tuusula, Finland
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website pharmia.fi
- Social LinkedIn
- Acquired by CapMan (Mar 2021)
- Legal Name Pharmia Oy
Products & Services of Pharmia
Pharmia offers a comprehensive portfolio of products and services, including Dietary Supplements, Medical Devices, Product Development, Raw Materials Sourcing, and Packaging Solutions.
Dietary supplements are developed and manufactured for clients.
Medical devices are offered for client branding needs.
Product development services are provided from idea to market.
Raw materials are sourced for product development needs.
Innovative packaging solutions are offered for client products.
Funding Insights of Pharmia
- Total Rounds 1
- Last Round Grant — $56,562
- First Round $56,562
(Mar 2016)
- Investors Count 1
All 1 funding rounds of Pharmia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2016 | $56,562 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Pharmia
Pharmia has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include CapMan, Labomar and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Diversified investment management firm | 1989 | capman.com | Helsinki, Finland | |
Dietary supplements, diet foods, health products, and medical devices | 1998 | labomar.com | Treviso, Italy |
Investor details for Pharmia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pharmia
Complete news archive for Pharmia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharmia
Pharmia was founded in 1994 and raised its 1st funding round 22 years after it was founded.
Pharmia is headquartered in Tuusula, Finland.
Pharmia is recognized as a leading Finnish contract manufacturer specializing in the development and production of dietary supplements and CE-marked medical devices across Europe. Services provided include comprehensive product development from ideation to market, raw material sourcing, and innovative packaging solutions. The company operates within the healthcare sector, ensuring high-quality standards with ISO 13485 and FSSC 22000 certifications. Production processes are managed meticulously, covering everything from material procurement to final product delivery. Clients are supported with tailored formulations and competitive offers during the development phase. Emphasis is placed on quality assurance through external laboratory analyses and consistent product standards.
Pharmia offers Dietary Supplements, Medical Devices, Product Development, Raw Materials Sourcing, and Packaging Solutions.
Pharmia operates through Pharmia Oy.
Yes. Pharmia was acquired by CapMan in March 2021.